‘From a economic perspective, Aflac U.S. Continued to perform well for the quarter and for the entire year. While new product sales growth has been constrained, our top-line growth has been strong over summer and winter consistently, reflecting an improvement in persistency primarily. With an increase of than 90 percent of our accounts arriving through the tiny business market, we continue steadily to find that segment as particularly susceptible to economic uncertainty. Given this backdrop, Aflac U.S.Related StoriesBU researcher gets prestigious fellowship to launch new project for people with dementiaMayo Clinic's Florida campus awarded NIH grant to recognize vascular risk factors in aging and dementiaHealth Education England launches Dementia Core Skills Education and Teaching FrameworkSpecifically: Sufferers within the therapeutic range less than 25 % of the time were 4.5 times more likely to develop dementia. Patients within the therapeutic range 25-50 % of that time period were 4.1 times much more likely to develop dementia.